Secondary analysis of EAST-AFNET 4 (2779 patients with AF, 216 with cancer history): early rhythm control reduced the primary cardiovascular composite with or without cancer, but safety events signalled higher with cancer (31% vs 20%; Pinteraction 0.055).
Secondary analysisn = 2,779
Ismaili et al. Early rhythm control in patients with atrial fibrillation and cancer: a subgroup analysis of the EAST-AFNET 4 trial